Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | S1PR5 | Q9H228 | 8/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.34 |
| ▸ | PRKDC | P78527 | 4/20 | 0.33 |
| ▸ | TNKS | O95271 | 2/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24280155 | 0.90 | ALOX5 (0.41) | ALOX5S1PR5S1PR4PRKDCTNKS | |
| SCHEMBL24280663 | 0.90 | ALOX5 (0.41) | ALOX5PRKDCTNKSTNKS2PARP14 | |
| SCHEMBL24280710 | 0.90 | ALOX5 (0.43) | ALOX5PRKDCTNKSTNKS2PARP14 | |
| SCHEMBL24280656 | 0.89 | ALOX5 (0.42) | ALOX5PRKDCTNKSTNKS2PARP14 | |
| SCHEMBL24280858 | 0.89 | ALOX5 (0.42) | ALOX5PRKDCTNKSTNKS2PARP14 | |
| SCHEMBL24266758 | 0.89 | ALOX5 (0.51) | ALOX5S1PR5S1PR4PRKDCPARP14 | |
| SCHEMBL22274643 | 0.88 | ALOX5 (0.41) | ALOX5PRKDCTNKSTNKS2PARP14 | |
| SCHEMBL15501735 | 0.87 | ALOX5 (0.48) | ALOX5S1PR5S1PR4PRKDCTNKS | |
| SCHEMBL24280548 | 0.87 | ALOX5 (0.49) | ALOX5PRKDCTNKSTNKS2PARP14 | |
| SCHEMBL24281044 | 0.87 | ALOX5 (0.41) | ALOX5PRKDCTNKSTNKS2PARP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
| WO-2020153758-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | ALDH1A2, OXER1, AOX1 | ALOX5 862/4885S1PR5 3072/4885S1PR4 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.